PT3289070T - Composição de meio para a preparação de toxina botulínica - Google Patents

Composição de meio para a preparação de toxina botulínica

Info

Publication number
PT3289070T
PT3289070T PT167867522T PT16786752T PT3289070T PT 3289070 T PT3289070 T PT 3289070T PT 167867522 T PT167867522 T PT 167867522T PT 16786752 T PT16786752 T PT 16786752T PT 3289070 T PT3289070 T PT 3289070T
Authority
PT
Portugal
Prior art keywords
botulinum toxin
medium composition
preparing botulinum
preparing
composition
Prior art date
Application number
PT167867522T
Other languages
English (en)
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of PT3289070T publication Critical patent/PT3289070T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT167867522T 2015-04-28 2016-04-28 Composição de meio para a preparação de toxina botulínica PT3289070T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150059655A KR101729251B1 (ko) 2015-04-28 2015-04-28 보툴리눔 독소의 제조를 위한 배지 조성물

Publications (1)

Publication Number Publication Date
PT3289070T true PT3289070T (pt) 2020-07-16

Family

ID=57199640

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167867522T PT3289070T (pt) 2015-04-28 2016-04-28 Composição de meio para a preparação de toxina botulínica

Country Status (20)

Country Link
US (1) US10117927B2 (pt)
EP (1) EP3289070B1 (pt)
JP (2) JP2018506262A (pt)
KR (1) KR101729251B1 (pt)
CN (1) CN107109353A (pt)
AR (1) AR104676A1 (pt)
AU (1) AU2016253789B2 (pt)
BR (1) BR112017012889A2 (pt)
CA (1) CA2968044C (pt)
DK (1) DK3289070T3 (pt)
ES (1) ES2805726T3 (pt)
HR (1) HRP20201067T1 (pt)
HU (1) HUE050244T2 (pt)
MX (1) MX2017008199A (pt)
PL (1) PL3289070T3 (pt)
PT (1) PT3289070T (pt)
RU (1) RU2689705C2 (pt)
SA (1) SA517381722B1 (pt)
TW (1) TWI592485B (pt)
WO (1) WO2016175566A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723167B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR102209159B1 (ko) * 2019-03-29 2021-01-29 (주)제테마 독소의 제조방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB790521A (en) 1955-11-15 1958-02-12 Bristol Lab Inc Improvements in or relating to antibiotics
WO2000001840A1 (en) 1998-07-03 2000-01-13 Dsm N.V. Fermentation process to produce clavulanic acid at a low concentration of free amino acids
US6558926B1 (en) 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products
RU2230325C2 (ru) * 2002-08-15 2004-06-10 Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации Способ приготовления очищенного препарата ботулинического токсина типа а
US7160699B2 (en) 2003-09-25 2007-01-09 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
US7148041B2 (en) 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
ES2317066T3 (es) 2003-10-17 2009-04-16 Ranbaxy Laboratories Limited Produccion de tacrolimus (fk-506)utilizando nuevas especies de streptomyces.
WO2006042542A2 (en) * 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
CA2556537A1 (en) * 2005-03-03 2006-09-03 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
FR2918671B1 (fr) * 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
CN101698826A (zh) * 2007-12-19 2010-04-28 杨宇 胰酪胨肉毒梭菌增菌肉汤
KR20090120222A (ko) * 2008-05-19 2009-11-24 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
CN103215310B (zh) * 2013-03-27 2015-01-21 中棉紫光生物科技(上海)有限公司 用于发酵的棉籽蛋白及其制备方法和应用
KR101339349B1 (ko) 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
HUE050244T2 (hu) 2020-11-30
RU2689705C2 (ru) 2019-05-28
DK3289070T3 (da) 2020-07-27
HRP20201067T1 (hr) 2021-02-05
JP2018506262A (ja) 2018-03-08
RU2017120813A (ru) 2018-12-14
ES2805726T3 (es) 2021-02-15
KR20160127998A (ko) 2016-11-07
EP3289070A4 (en) 2018-09-26
CN107109353A (zh) 2017-08-29
EP3289070B1 (en) 2020-05-06
TW201638329A (zh) 2016-11-01
CA2968044A1 (en) 2016-11-03
TWI592485B (zh) 2017-07-21
JP2020072649A (ja) 2020-05-14
EP3289070A1 (en) 2018-03-07
RU2017120813A3 (pt) 2018-12-14
MX2017008199A (es) 2017-12-04
PL3289070T3 (pl) 2020-11-16
WO2016175566A1 (en) 2016-11-03
KR101729251B1 (ko) 2017-04-21
US10117927B2 (en) 2018-11-06
US20170252431A1 (en) 2017-09-07
AU2016253789B2 (en) 2018-12-06
CA2968044C (en) 2022-08-09
AU2016253789A1 (en) 2017-06-01
AR104676A1 (es) 2017-08-09
BR112017012889A2 (pt) 2018-01-30
JP6887467B2 (ja) 2021-06-16
SA517381722B1 (ar) 2021-03-07

Similar Documents

Publication Publication Date Title
HK1231509A1 (zh) 培養基組合物
HUE051027T2 (hu) Tenyésztõ tápközeg
IL253429A0 (en) A container filled with botulinum toxin
GB201505527D0 (en) Composition
GB201506827D0 (en) Composition
EP3383889A4 (en) PROCESS FOR THE PREPARATION OF BOTULINUM TOXIN
PT3289069T (pt) Composição de meio para a preparação de toxina botulínica
GB201506829D0 (en) Composition
GB201506830D0 (en) Composition
GB201506825D0 (en) Composition
PT3289070T (pt) Composição de meio para a preparação de toxina botulínica
GB201506828D0 (en) Composition
GB201504307D0 (en) Composition
GB201509044D0 (en) Composition
GB201505520D0 (en) Composition
GB201504665D0 (en) Composition
EP3289071A4 (en) Medium composition for preparing botulinum toxin
SG10202003691PA (en) Composition for modulating irak1
GB201508722D0 (en) Composition
GB201506826D0 (en) Composition
GB201509641D0 (en) Composition
HK1259489A1 (zh) 酶原組合物
IL259259B1 (en) A pro-enzymatic preparation
GB201515015D0 (en) Culture medium
GB201603407D0 (en) Culture medium